CALL for VOLUNTEERS
The Department of Medicine at UMDNJ-Robert Wood Johnson Medical School in New Brunswick is looking for volunteers between the ages of 65 and 90 to participate in a 14-week diabetes study of an FDA-approved diabetes medication. To be eligible, volunteers must not now be taking medication to control their blood sugar. Participants will receive a physical exam, study tablets and relevant laboratory tests at no cost.
The principal investigator for the study is Avedis K. Khachadurian, MD. For more information call Shelley Greenhaus, RN, at 732-235-7751.
An investigational drug study for diabetic neuropathy is being conducted at UMDNJ-Robert Wood Johnson Medical School in New Brunswick. Individuals with diabetes mellitus experiencing numbness or pain in their hands or feet may be eligible to participate. Participants will receive at no cost a physical exam, study tablets, relevant laboratory tests and a nerve biopsy, which is required. Monetary compensation of $1,250 will be provided upon completion of the study.
A second investigational drug study is being conducted at the school to test a new diabetes pill for the treatment of Type II diabetes mellitus. Volunteers with diabetes between the ages of 21 and 79 are needed to participate. Monetary compensation is provided to those who qualify and there is no charge for a physical exam, study medications and relevant laboratory tests.
Stephen H. Schneider, MD, Division of Endocrinology, Metabolism and Nutrition, is the principal investigator for both studies. For more information on both studies, call Shelley Greenhaus, RN, at 732-235-7751.
Type II Diabetes
The Division of Endocrinology, Metabolism and Nutrition at UMDNJ-Robert Wood Johnson Medical School in New Brunswick is conducting an investigational drug study for individuals with Type II diabetes, between the ages of 30 and 79, who are currently taking one or more oral medications for diabetes. The drugs used in the study are FDA approved. Those considered will receive free study medications, glucose monitoring supplies, relevant laboratory tests and a physical exam. The study will provide a reasonable reimbursement for time and travel up to a fixed amount.
Stephen H. Schneider, MD, is the principal investigator. For more information call Shelley Greenhaus, RN, at 732-235-7751.
Women Needed to Participate in an Alzheimers Disease Study
Women are being sought to participate in a three-year research study to determine whether estrogen replacement therapy reduces the risk of developing memory loss and maintains memory in older women who are not currently experiencing memory problems. Participants must be age 65 and older and have had a parent or sibling diagnosed with Alzheimers disease. Related medical care, including study medications,will be prescribed at no cost while patients are enrolled in the study. Other screening and eligibility requirements must also be met.
The study is being conducted at UMDNJ-Robert Wood Johnson Medical School in Piscataway and is funded by the National Institutes of Health. Peter Aupperle, MD, University Behavioral HealthCare, is the principal investigator. For more information call Julie Coleman, RN, BSN, at 732-235-4907.
UMDNJ-Robert Wood Johnson Medical School in Piscataway is conducting a 12-week study on Down syndrome. The goal of the study is to determine if a drug which is FDA approved for the treatment of mild to moderate dementia of Alzheimers type will improve attention, language and memory in patients who have Down syndrome but no memory problems. To qualify, volunteers must be between the ages of 18 and 35 and have Down syndrome.
Participants and their caregiver or a family member are required to attend a total of four sessions during the study period. Patients will receive daily oral medication or inactive placebo. At the end of the study, all participants will have the option of receiving active medication for an additional 12 weeks.
The study is under the direction of the principal investigator Peter Aupperle, MD, University Behavioral HealthCare. For additional information call Julie Coleman, RN, BSN, at 732-235-4907.
A research study is being conducted at UMDNJ-Robert Wood Johnson Medical School in Piscataway. The goal of the 12-week study (includes a total of five visits) is to evaluate the safety and effectiveness of a drug that assists patients who have memory loss who are also experiencing agitation, restlessness or anxiety. To be eligible, volunteers must be age 60 and older and in good health with a diagnosis of memory loss due to some type of dementia. Related medical care, including study medications, will be prescribed at no cost while patients are enrolled. Other screening and eligibility requirements must also be met.
William Reichman, MD, University Behavioral HealthCare, is the principal investigator for the study. For more details call Julie Coleman, RN, BSN, at 732-235-4907.
Environmental Health Research Study
Women are needed to participate in a study at UMDNJ-Robert Wood Johnson Medical School in Piscataway to evaluate the health effects of indoor air quality and stress. To be eligible, volunteers must be healthy non-smokers between the ages of 20 and 45, and be available for a five hour morning session (once a week) for four consecutive weeks. During these sessions, responses to indoor air (typical of office environments) will be measured. Participants will also fill out questionnaires, be given tests of attention and concentration, and be asked to provide nasal and saliva samples. A medical exam will be provided at no cost, and upon completion of the study, participants will receive monetary compensation.
Nancy Fiedler, PhD, Environmental & Occupational Health Sciences Institute, is the principal investigator for the study. For more information call 732-445-0123, ext. 625.
Uterine Lining Study
The National Institutes of Health, in conjunction with the Department of Obstetrics, Gynecology and Womens Health, is conducting a study to test the uterine lining in both fertile and infertile women. To qualify, participants must be between the ages of 25 and 39, have regular menstrual cycles and have had a child in the last 23 months. Participants will be compensated for time and travel.
Peter McGovern, MD, is the principal investigator for the study.For more information call the study coordinator Amy Solnica, RN, at 201-393-7430 or 888-777-8922, ext. 7430.
Oral and Vaginal Hormone Treatment
Menopausal women experiencing vaginal dryness and painful intercourse are being sought to participate in a seven-month oral and vaginal hormone treatment study at UMDNJ-Robert Wood Johnson Medical School in New Brunswick. Participants will receive a physical examination, mammogram, laboratory test and Pap smear at no cost, and will be paid $175 upon completion of the study. Monetary compensation will be prorated if the volunteer does not complete the study.
Gloria Bachmann, MD, Womens Health Institute, is the principal investigator for the study. For more information call 732-235-7353 or 732-235-7799, Monday thru Friday from 8 AM to 4 PM.
Treatment for Osteoporosis in Postmenopausal Women
Postmenopausal women are needed to participate in a one year medical research study for the treatment of osteoporosis at UMDNJ-Robert Wood Johnson Medical School in New Brunswick. The study will collect information on two approved, marketed medications for this condition.
Volunteers must be age 40 and older to be considered. Participants will receive study medication, study related physician visits, laboratory tests and bone density (osteoporosis) testing. In addition, they will receive $150 upon the completion of the study.
Gloria Bachmann, MD, Womens Health Institute, is the principal investigator for the study. For more information call 732-235-7292 or 732-235-7799.
The Clinical Research Center at UMDNJ-Robert Wood Johnson Medical School in New Brunswick is seeking volunteers with psoriasis to participate in research studies being conducted at the school. Eligible participants will receive physical examinations by board-certified dermatologists, laboratory tests and medication at no cost. Some programs have monetary compensation.
This study is under the direction of Alice B. Gottlieb, MD, PhD. For further details and to find out if you qualify, call Nancy Olesinski at 732-418-8484.
A group of neurologists from throughout the U.S. and Canada, known as the Parkinsons Study Group (PSG), have formed a collaborative effort with Indiana University School of Medicine, University of Rochester, The Ohio State University, Childrens Hospital Medical Center at the University of Cincinnati and Emory University to study genetic and other risk factors which may be important in the development of Parkinsons disease. This study, PROGENI (Parkinsons Research: The Organized Genetics Initiative), is being sponsored by the National Institutes of Health and will involve 400-600 pairs of brothers and sisters throughout North America who are affected, or possibly affected, with Parkinsons disease (PD).
Participation in this project is voluntary and will be limited to those individuals with living siblings affected or possibly affected with PD who are also willing to participate. To enroll in this project or to request additional information, contact Lisa Giffin, LPN, CCRC, Center for Aging in Stratford, at 856-566-6356. Those residing outside the United States should call 1-317-274-5734. Information about the study can also be obtained through a Web site (http://www.medgen.iupui.edu/research/parkinson).
Non-smokers between the ages of 15 and 65 with a history of asthma are needed to participate in a study to test a medication to treat asthma. Participants will receive free testing, examinations and generous compensation for time and travel.
The study is being conducted at Cooper Hospital/University Medical Centers Department of Medicine in Camden. The principal investigator is Robin Gross, MD. For further information call Robin Gross, MD, at 856-342-2407 or Patricia Niblack, MLT, at 856-968-7269.
At UMDNJ-New Jersey Medical School, a study is being conducted to investigate how the brain analyzes facial expressions in people with autism as compared with healthy individuals. It involves looking at photographs of faces while a magnetic resonance imaging (MRI) scan is being performed. Participants must be right-handed males between the ages of 18 and 30, in good physical health and with no history of mental illness. They will be required to make two visits to Newark over a period of a month and will receive financial compensation for their time and travel.
Charles Cartwright, MD, Department of Psychiatry, is the principal investigator. For more information call the Autism Program at 973-972-1611.
The magazine of the University of Medicine and Dentistry of New Jersey